It remains an aggressive, debilitating and life-threatening cancer. Mortality is often as high as 60 percent because most children present with advanced disease that responds poorly to typical chemotherapy and other forms of treatment. Neuroblastoma offers both intrinsic and acquired drug resistance. Related StoriesViralytics enters into scientific trial collaboration contract with MSDFDA grants accelerated approval for Tagrisso to treat sufferers with advanced NSCLCNew RNA test of blood platelets can be used to identify area of cancerThe grant will fund a thorough research plan that involves tackling the condition systematically on several fronts to: acquire a thorough knowledge of the molecular basis of neuroblastoma by determining key genes and pathways associated with its initiation and perpetuation; understand the failing of specific biochemical signalling in defective cell differentiation; determine cancer-specific genes in neuroblastoma that are good candidates for the development of molecular targeted gene therapy; identify compounds having the ability to inhibit target genes; and translate novel anticancer therapies into medical applications.‘The depth of talent among the other finalists this season was stout, and we experience very proud to possess emerged on top. I believe another few years will be the most fascinating in the history of life research and healthcare marketing, and 2e shall be there at the forefront. This is the beginning just.’ Related StoriesDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixHealthcare technology cultural event of the year opens entriesOJ Bio at Medica 2015 – Stage of Care diagnostics' function in reducing antibiotics prescribingThe annual MM&M Awards ceremony, thursday in New York City that was attended by 850 industry leaders last, highlights the very best in healthcare marketing, communications, and media.